Abstract
It has been reported that most tumor cells show an increased uptake of variety of amino acids specially methionine when compared with normal cells and amino acid transport is generally increased in malignant transformation. Based on the evidences, two novel nanosized analogues of methionine (Anionic Linear Globular Dendrimer G2, a biodigredabale anionic linear globular-Methionin, and DTPA-Methionine1 conjugates) were synthesized and labeled with 99mTc and used in tumor imaging/ therapy in vitro and in vivo. The results showed marked tumor SPECT molecular imaging liabilities for both compounds but with a better performance by administration of 99mTc-Dendrimer G2-Methionin. The results also showed a good anticancer activity for 99mTc-DTPA-Methionine. Based on the present study 99mTc-Dendrimer G2-Methionin or 99mTc-DTPA-(Methionine)1 have potentials to be used in tumor molecular imaging as well as cancer therapy in future.
Keywords: Tumor cells, nanosized, methionine, DTPA, dendrimer G2, SPECT, amino acids, malignant transformation, nanosized analogues, globular-Methion
Current Medicinal Chemistry
Title:A Comparative Study of Two Novel Nanosized Radiolabeled Analogues of Methionine for SPECT Tumor Imaging
Volume: 20 Issue: 1
Author(s): A.G. Khosroshahi, M. Amanlou, O. Sabzevari, F.J. Daha, M.R. Aghasadeghi, M. Ghorbani, M.S. Ardestani, M.S. Alavidjeh, S.M. Sadat, M.H. Pouriayevali, L. Mousavi and S.E.S. Ebrahimi
Affiliation:
Keywords: Tumor cells, nanosized, methionine, DTPA, dendrimer G2, SPECT, amino acids, malignant transformation, nanosized analogues, globular-Methion
Abstract: It has been reported that most tumor cells show an increased uptake of variety of amino acids specially methionine when compared with normal cells and amino acid transport is generally increased in malignant transformation. Based on the evidences, two novel nanosized analogues of methionine (Anionic Linear Globular Dendrimer G2, a biodigredabale anionic linear globular-Methionin, and DTPA-Methionine1 conjugates) were synthesized and labeled with 99mTc and used in tumor imaging/ therapy in vitro and in vivo. The results showed marked tumor SPECT molecular imaging liabilities for both compounds but with a better performance by administration of 99mTc-Dendrimer G2-Methionin. The results also showed a good anticancer activity for 99mTc-DTPA-Methionine. Based on the present study 99mTc-Dendrimer G2-Methionin or 99mTc-DTPA-(Methionine)1 have potentials to be used in tumor molecular imaging as well as cancer therapy in future.
Export Options
About this article
Cite this article as:
Khosroshahi A.G., Amanlou M., Sabzevari O., Daha F.J., Aghasadeghi M.R., Ghorbani M., Ardestani M.S., Alavidjeh M.S., Sadat S.M., Pouriayevali M.H., Mousavi L. and Ebrahimi S.E.S., A Comparative Study of Two Novel Nanosized Radiolabeled Analogues of Methionine for SPECT Tumor Imaging, Current Medicinal Chemistry 2013; 20 (1) . https://dx.doi.org/10.2174/0929867311302010012
DOI https://dx.doi.org/10.2174/0929867311302010012 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmacological Strategies to Overcome HER2 Cross-Talk and Trastuzumab Resistance
Current Medicinal Chemistry Cyclooxygenases in the Central Nervous System: Implications for Treatment of Neurological Disorders
Current Pharmaceutical Design Cyclophilin function in Cancer; lessons from virus replication
Current Molecular Pharmacology Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?
Current Pharmaceutical Design Anti-Carcinogenic Effects of Carnosol-An Updated Review
Current Drug Discovery Technologies Vagotomy and Gastric Tumorigenesis
Current Neuropharmacology Molecular Predictors of Efficacy to Anti-EGFR Agents in Colorectal Cancer Patients
Current Cancer Drug Targets Role of Tumor Microenvironment in Cancer Stem Cells Resistance to Radiotherapy
Current Cancer Drug Targets Anticancer Drug Combinations, How Far We can Go Through?
Anti-Cancer Agents in Medicinal Chemistry Recent Advances of Natural and Synthetic β-Carbolines as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Flavonoids and other Non-alkaloidal Constituents of Genus Erythrina: Phytochemical Review
Combinatorial Chemistry & High Throughput Screening Convection Enhanced Drug Delivery of Novel Therapeutic Agents to Malignant Brain Tumors
Current Drug Delivery Synthesis and Antitumoral Evaluation of 7-chloro-4-quinolinylhydrazones Derivatives
Medicinal Chemistry Do We have a Satisfactory Cell Viability Assay? Review of the Currently Commercially-Available Assays
Current Drug Discovery Technologies Cellular Efflux of cAMP and cGMP - A Question about Selectivity
Mini-Reviews in Medicinal Chemistry Design, Preparation and Characterization of Modular Squalene-based Nanosystems for Controlled Drug Release
Current Topics in Medicinal Chemistry Computer Aided Drug Design Approaches for Identification of Novel Autotaxin (ATX) Inhibitors
Current Medicinal Chemistry Lapatinib as a Chemotherapeutic Drug
Recent Patents on Anti-Cancer Drug Discovery Matrix Metalloproteinase Inhibitor MMI-166 Suppresses the Growth of SW1990 Human Pancreatic Cancer Cells
Current Signal Transduction Therapy Recent Advances in Efficacy of using Doxorubicin Gold Nanoparticles for Chemo-, Radio-, Photothermal, and Photodynamic Therapy
Current Drug Delivery